Treatment breaks in osteoporosis – what pharmacists need to know. Clinical Brief Series - The Australian Pharmacy Council


1 hr



# of Credits



APC - Group 2 CPD

Expiry Date


This is a 4-part Clinical Brief series that has been accredited with APC. Participants must read all 4 issues and then complete the questions on Issue 4 to claim Group 2 CPD Credits. This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1 hour of Group 2 CPD (2 CPD credits) upon successful completion of relevant assessment activities.

This activity has been accredited for 1.00 hour(s) of Group 2 CPD (or 2 CPD Credits) suitable for inclusion in an individual pharmacist’s CPD plan

Aleksandra Erac-Zganec
BPharm, PGDip Clin Pharm, PG Cert Clin Mgmt Pain,
PG Cert Mgmt, Brisbane,
Pharmacist, Brisbane, QLD

On completion of this program, participants will be better able to:

  1. Discuss the pharmacological treatment options used in the management of osteoporosis
  2. Recall the different mechanisms of action and duration of effect of osteoporosis pharmacotherapies
  3. Describe the issues associated with discontinuing osteoporosis pharmacotherapy
  4. Recall the prescribing rationale for enteric coated once weekly risedronate
  5. Counsel patients on the safety and efficacy of long-term osteoporosis pharmacotherapy

Related Courses